Pharmacokinetics of a topical application of moxidectin in bare-nosed wombats (Vombatus ursinus).


Journal

Veterinary parasitology, regional studies and reports
ISSN: 2405-9390
Titre abrégé: Vet Parasitol Reg Stud Reports
Pays: Netherlands
ID NLM: 101680410

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 22 02 2024
revised: 12 06 2024
accepted: 24 06 2024
medline: 19 7 2024
pubmed: 19 7 2024
entrez: 18 7 2024
Statut: ppublish

Résumé

Sarcoptic mange is a debilitating disease that affects bare-nosed wombats (Vombatus ursinus). One of the drugs currently used for treatment is moxidectin, as it has a relatively high efficacy against endo and ectoparasites and side effects are uncommon in domestic species, thus it is considered a relatively safe drug to use at the recommended doses. Developing further understanding of the pharmacokinetics of moxidectin will aid in developing treatment regimens for sarcoptic mange in wombats. Here we analyzed the pharmacokinetic parameters of using 100 ml of moxidectin (5 g/l) applied topically. We found that mean peak plasma concentration was 0.50 ng/ml and half-life was 8 days. Moxidectin was excreted in scats with the mean peak concentration of 2461.43 ng/g (on a dry matter basis). Our study has provided the pharmacokinetic parameters of a commonly used treatment for sarcoptic mange in wombats. There were no adverse side effects recorded in the wombats after applying moxidectin topically. This study replicated real-world conditions using topical application on free-living wombats. The relatively low plasma concentration suggests the drug is not accumulating in the blood stream and is excreted via scats.

Identifiants

pubmed: 39025544
pii: S2405-9390(24)00094-7
doi: 10.1016/j.vprsr.2024.101074
pii:
doi:

Substances chimiques

moxidectin NGU5H31YO9
Macrolides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101074

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Hayley Stannard reports financial support was provided by Wombat Protection Society of Australia. Marie Wynan reports a relationship with Wombat Protection Society of Australia that includes: board membership. Amanda Cox reports a relationship with Wombat Protection Society of Australia that includes: board membership. The other authors, declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Hayley J Stannard (HJ)

School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia. Electronic address: hstannard@csu.edu.au.

Marie B Wynan (MB)

Jarake Wildlife Sanctuary Ltd, Nimmitabel, NSW, Australia; Wombat Protection Society of Australia, Tomerong, NSW, Australia.

Ray J Wynan (RJ)

Jarake Wildlife Sanctuary Ltd, Nimmitabel, NSW, Australia.

Amanda Cox (A)

Wombat Protection Society of Australia, Tomerong, NSW, Australia.

Howard Ralph (H)

Southern Cross Wildlife Care, Braidwood, NSW, Australia.

Gregory S Doran (GS)

School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia; Gulbali Institute, Charles Sturt University, Albert Pugsley Place, Wagga Wagga, NSW, Australia.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH